Thursday November 26 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Inotek Corporation

Free radical and oxidant-mediated diseases.


Contact Details:
Beverly
MA
United States of America
Tel:
Fax:
Email:

Recent Publications by Inotek Corporation:

Facile and convenient syntheses of 6,11-dihydro-5H-indeno[1,2-c]isoquinolin- 5-ones and 6,11-dihydro-5H-indolo[3,2-c]isoquinolin-5-one.
[reaction: see text] The synthesis of...
10th February, 2006
Inotek Pharmaceuticals Corporation, 100 Cummings Center, Beverly, Org Lett. 2005 Apr 28;7(9):1753-6.
DOI Direct Link
Mechanisms of cell necrosis.
Amiloride-sensitive, epithelial Na(+) channel (ENaC)-mediated, active...
19th January, 2006
Inotek Pharmaceuticals Corporation, Beverly, MA, USA. Crit Care Med. 2005 Dec;33(12 Suppl):S530-4.
Gender differences in the endotoxin-induced inflammatory and vascular responses: potential role of poly(ADP-ribose) polymerase activation.
Activation of poly(ADP-ribose) polymerase (PARP) is an important factor in...
13th January, 2006
Inotek Pharmaceuticals Corporation, Beverly, Massachusetts, USA. J Pharmacol Exp Ther. 2005 Nov;315(2):812-20. Epub 2005 Aug 3.
DOI Direct Link
Cytokines stimulate expression of inducible nitric oxide synthase in DLD-1 human adenocarcinoma cells by activating poly(A) polymerase.
OBJECTIVE: The stimulation of epithelial cells by cytokines or...
3rd November, 2005
Inotek Pharmaceuticals Corporation, 100 Cummings Center, Suite 419E, Inflamm Res. 2004 Nov;53(11):604-8.
Angiotensin II-mediated endothelial dysfunction: role of poly(ADP-ribose) polymerase activation.
Angiotensin II (AII) contributes to the pathogenesis of many...
20th October, 2005
Inotek Pharmaceuticals Corporation, Suite 419E, 100 Cummings Center, Mol Med. 2004 Jan-Jun;10(1-6):28-35.

View more Inotek Corporation research publications.

Inotek Corporation Clinical Trials:

A Study of INO-1001, an Intravenous PARP (Poly [ADP Ribose] Polymerase) Inhibitor in Acute Heart Attack Patients Undergoing Primary Percutaneous Coronary Intervention

Inotek Corporation Patents:

US Patent No.Title
7432369 Pyridyl-substituted porphyrin compounds and methods of use thereof
6534651 7-Substituted isoindolinone inhibitors of inflammation and reperfusion injury and methods of use thereof
6531464 Methods for the treatment of neurodegenerative disorders using substituted phenanthridinone derivatives
6476048 Substituted phenanthridinones and methods of use thereof
6281222 Compositions and method for treatment of acetaminophen intoxication

View more Inotek Corporation patents.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 20 individuals from Inotek Corporation using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 281 times since April 2007, the link to the organisation's website has been followed 0 times

Search for more companies in Beverly

Search for more companies in MA



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Inotek Corporation

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.